HRTX FY 2016 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M97.3% margin

Operating Income

-$171M-13363.2% margin

Net Income

-$173M-13537.4% margin

EPS (Diluted)

$-4.57

Cash Flow

Operating Cash Flow

-$134M

Free Cash Flow

-$137M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$67M

Total Liabilities

$89M

Stockholders' Equity

-$21M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	-$734,000	+269.5%
Operating Income	-$171M	-$97M	-76.3%
Net Income	-$173M	-$98M	-77.4%